ImmuCell Corporation ICCC
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +66.83%
- 1 year
- +68.47%
- Open
- 10.25
- Prev close
- 10.54
- Mkt cap
- 93.18M
- Vol
- 11.02K
- Avg vol
- 18.05K
- EPS
- 0.07
- P/E
- 146.57
- Div yield
- 0.00%
More statistics
- Low
- 9.98
- High
- 10.36
- Forward P/E
- -42.82
- Beta
- 0.57
- Short ratio
- 0.23
- Inst. own
- 14.51%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.93
- 200-d avg
- 4.28
- 1y target
- 0.00
News
-
2 weeks ago benzinga.com
ImmuCell Reports Q3 Preliminary Sales Of $8M, Up 46% YoY
ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity,
2 months ago benzinga.com
ImmuCell Reports Q2 2026 Results: Full Earnings Call Transcript
ImmuCell (NASDAQ:ICCC) released second-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive…
-
2 months ago benzinga.com
ImmuCell Q2 EPS $0.20 Up From $0.06 YoY, Sales $7.186M Up From $6.445M YoY
ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.20 per share. This is a 233.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported $7.186…
-
3 months ago benzinga.com
ImmuCell Q2 Total Product Sales Rises 12%
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity,
-
5 months ago benzinga.com
ImmuCell Q1 EPS $0.21 Up From $0.16 YoY, Sales $10.357M Up From $8.067M YoY
ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.21 per share. This is a 31.25 percent increase over earnings of $0.16 per share from the same period last year. The company reported $10.357…
-
5 months ago benzinga.com
ImmuCell And Norbrook Laboratories Reach Settlement Agreement, Norbrook To Pay $2M Following Expiration Of 2019 Supply Deal
On May 8, 2026, ImmuCell Corporation and Norbrook Laboratories Limited (incorporated and registered in Northern Ireland) entered into a Settlement Deed to resolve and release any and all claims…
-
6 months ago benzinga.com
ImmuCell Reports Q1 Preliminary Sales $10.4M Up From 28.4% YoY
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity, today…
-
8 months ago benzinga.com
ImmuCell Q4 EPS $(0.31) Down From $0.06 YoY, Sales $7.626M Down From $7.751M YoY
ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.31) per share. This is a 616.67 percent decrease over earnings of $0.06 per share from the same period last year. The company reported $7.626…
-
-
9 months ago benzinga.com
ImmuCell Reports Q4 Preliminary Net Sales Of $7.6M; Domestic Sales Were $7.0M In 2025, An 8.7% Increase Compared To 2024
ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, today…
-
10 months ago benzinga.com
ImmuCell Pauses Re-Tain Drug After FDA Setback, Shifts Focus to Expanding First Defense Business
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell"), an animal health company that develops, manufactures and markets products that improve cattle health and productivity today announced that it…
10 months ago benzinga.com
ImmuCell Puts Re-Tain On Pause After FDA Letter
Animal health company ImmuCell receives an Incomplete Letter from the FDA for its Re-Tain NADA. Company shifts focus to First Defense.
10 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
10 months ago benzinga.com
ImmuCell Has Decided To Pause Further Investment In Re-Tain
In seeking FDA approval to bring its innovative Re-Tain® product to market, ImmuCell received Complete Letters from the FDA for four of the five Technical Sections required for NADA approval. It…
-
10 months ago benzinga.com
ImmuCell Increasing First Defense Field Sales Force By 50%, Expanding First Defense Production Capabilities After Receiving FDA's Incomplete Letter For Its Re-Tain New Animal Drug Application
ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell"), an animal health company that develops, manufactures and markets products that improve cattle health and productivity today announced that it received…
-
11 months ago benzinga.com
ImmuCell Q3 EPS $(0.02) Up From $(0.09) YoY, Sales $5.506M Down From $6.012M YoY
ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.02) per share. This is a 77.78 percent increase over losses of $(0.09) per share from the same period last year. The company reported $5.506…
-
11 months ago benzinga.com
Earnings Scheduled For November 13, 2025
Earnings Scheduled For November 13, 2025
-
1 year ago benzinga.com
Earnings Scheduled For August 14, 2025
Earnings Scheduled For August 14, 2025
-
1 year ago benzinga.com
Earnings Scheduled For February 25, 2025
Earnings Scheduled For February 25, 2025
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
1 year ago benzinga.com
Earnings Scheduled For November 13, 2024
Earnings Scheduled For November 13, 2024
-
2 years ago benzinga.com
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
-
2 years ago benzinga.com
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
-
3 years ago benzinga.com
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 199 companies reached new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Thursday's session saw 337 companies set new 52-week lows.
-
3 years ago benzinga.com
Earnings Scheduled For February 21, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is likely to report earnings for its fourth quarter.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 400 companies set new 52-week lows.
-
4 years ago benzinga.com
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
-
4 years ago benzinga.com
Earnings Scheduled For May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.
-
4 years ago benzinga.com
Earnings Scheduled For November 15, 2021
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter.
-
5 years ago benzinga.com
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
-
5 years ago benzinga.com
Earnings Scheduled For May 13, 2021
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
During Friday's morning session, 57 stocks hit new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Wednesday
-
7 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday